Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$61.71 - $77.76 $31,101 - $39,191
504 Added 13.44%
4,254 $324,000
Q2 2023

Aug 07, 2023

SELL
$81.41 - $94.33 $179,102 - $207,526
-2,200 Reduced 36.97%
3,750 $353,000
Q1 2023

May 01, 2023

SELL
$74.26 - $84.51 $37,724 - $42,931
-508 Reduced 7.87%
5,950 $492,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $22,060 - $28,243
323 Added 5.26%
6,458 $482,000
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $193,981 - $252,667
2,355 Added 62.3%
6,135 $508,000
Q2 2021

Jul 15, 2021

SELL
$83.84 - $104.76 $276,672 - $345,708
-3,300 Reduced 46.61%
3,780 $392,000
Q1 2021

Apr 23, 2021

SELL
$78.68 - $90.67 $3.96 Million - $4.56 Million
-50,300 Reduced 87.66%
7,080 $592,000
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $1.43 Million - $1.82 Million
20,000 Added 53.5%
57,380 $5.23 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $221,727 - $288,552
3,300 Added 9.68%
37,380 $2.98 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.48 Million - $1.98 Million
25,690 Added 306.2%
34,080 $2.36 Million
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $30,921 - $47,790
-590 Reduced 6.57%
8,390 $1.58 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $152,721 - $174,851
2,130 Added 31.09%
8,980 $2.1 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $236,967 - $290,405
3,850 Added 128.33%
6,850 $1.51 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $167,220 - $193,230
3,000 New
3,000 $554,000
Q1 2019

May 13, 2019

SELL
$47.89 - $64.05 $23,945 - $32,025
-500 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$42.45 - $51.3 $10,612 - $12,825
250 Added 100.0%
500 $73,000
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $43,548 - $46,596
-1,200 Reduced 82.76%
250 $27,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,450
1,450 $172,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.